To achieve its objectives of discovering and developing safe, effective and affordable medicines to treat infectious diseases, particularly those prevalent in sub-Saharan Africa,

iThemba Pharmaceuticals has developed a robust pipeline of carefully selected molecular scaffolds for relevant biological targets that offer promise for treating infectious diseases of interest, particularly TB.